Home » Newsletters » BioWorld Science

BioWorld Science

April 24, 2000

View Archived Issues

BioQuest and Biovector Therapeutics to collaborate on HIV vaccine

Dura expands inhaler technology platform

Pharmacia to use Biacore's lead selection technology

Lundbeck and M&E Biotech to cooperate on neurodegenerative disease research

Humalog now available in Europe to treat children with diabetes

Idec enters two agreements for prostate cancer immunotherapy

Corixa receives milestone from Organon for RA collaboration

Raloxifene shows good uterine safety profile

Lilly and Arena to develop GPCRs as screening targets

Coley initiates phase I/II trials of CpG-7909 for cancer

Company Profile: Renovo

Apoptosis-initiating gene acquired by Idun

NIH research sheds light on chronic hepatitis C

CV Therapeutics develops sustained-release formulations of ranolazine

ATP-sensitive K+ channel blockers reportedly useful for vagal nervous system dysfunction

Novel compounds that inhibit hematopoietic cell activation in development at AstraZeneca

Immunomodulators from Gruenenthal affect IL-10 and IL-12 production

Aventis prepares new selective factor VIIa inhibitors

Preparation, activity and use of inhibitors of Th2-type cytokine production described by Sumitomo

Teveten now available in the U.K. for the treatment of hypertension

Anti-HIV activity demonstrated for natural product used in Japan for hepatitis

New controlled-release, microencapsulated HBV vaccine prepared in China

DepoMed reports phase I results for Metformin GR

Biovector Therapeutics initiates phase II trial of melanoma vaccine

Inhalable MS drug enters phase I trials

BMS temporarily withdraws Vanlev NDA

Artemis and Max Planck begin international genetic screening project with zebrafish

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...